<DOC>
	<DOCNO>NCT02074293</DOCNO>
	<brief_summary>Botox act nerve ending , yet nerve ending inside muscle , typically inject . All nerve terminate fascia , ASIS device precisely deliver Botox create subdermal bloodless space , skin muscle . Thus enhance prolong Botox 's efficacy , time prevent 's unnecessary adverse reaction distant spread , especially since Botox reason travel rest body way .</brief_summary>
	<brief_title>ASIS Botox Cervical Dystonia</brief_title>
	<detailed_description>Aim 1 6 month demonstrate ASIS device 's consistent performance 60 adult subject Cervical Dystonia . Gadolinium inject ASIS subdermally ( 30 ) conventional intramuscularly ( 30 ) 7 muscle group : Splenius , Scalene , Sterno-cleido-mastoid , Levator scapula , Semispinalis , Trapezius , Longissimus . An MRI take promptly Gadolinium injection , start reference , subsequent MRI take 6 hr , 12 hr , 24 hr later compare Persistent % . Since n't way measure level Gadolinium within , ( e.g . Botox ) matter , least Prolongation Gadolinium may approximate great longer Persistent % MRI . However , approximation work variable minimize population Cervical Dystonia , particular 7 muscle group . Case point , patient Cervical Dystonia presumably hyperactive Splenius , Scalene , Sterno-cleido-mastoid , Levator scapula , Semispinalis , Trapezius , Longissimus muscle , expectantly shorten Gadolinium intramuscularly Persistent % , somewhat reduced Gadolinium subdermally Persistent % well due agitation , thus Persistent % value Cervical Dystonia patient like normal patient , even 7 different muscle group . Therefore , Relative Prolongation Ability Score total Persistent % subdermally total Persistent % intramuscularly , specific valuable indicator help u modify Botox dosage duration inject `` unknown '' subdermal bloodless space Aim 2 . Aim 2 12 month , use Botox , instead Gadolinium , demonstrate advantage ASIS device subdermally intramuscularly , 60 adult subject Cervical Dystonia , particular 7 muscle group : Splenius , Scalene , Sterno-cleido-mastoid , Levator scapula , Semispinalis , Trapezius , Longissimus . Hypothetically speaking , subdermal bloodless space patient e.g. , Cervical Dystonia somehow fail show prolongation half-life Gadolinium Aim 1 , still proceed primary interest therapeutic comparison Botox Aim 2 , term improvement Physician Global Assessment Scale 6 , 12 , 18 , 24 , 30 week , reduction Cervical Dystonia Severity Scale ( CDSS ) well adverse reaction .</detailed_description>
	<mesh_term>Neck Pain</mesh_term>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>â€¢Adults cervical dystonia , abnormal head position neck pain 7 muscle group : Splenius , Scalene , Sternocleidomastoid , Levator scapula , Semispinalis , Trapezius , Longissimus . Known Hypersensitivity Botulinum Toxin component formulation . Infection Injection Site ( ) . Has medical condition may increase risk exposure Botox include diagnose myasthenia gravis , EatonLambert syndrome , amyotrophic lateral sclerosis , significant disease might interfere neuromuscular function . Has profound atrophy weakness muscle target area injection . Had previously receive surgical denervation treatment symptom know history neuromuscular disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Subdermal bloodless space</keyword>
	<keyword>Subdermal injection</keyword>
	<keyword>injectable EMG needle</keyword>
	<keyword>electrical stimulation</keyword>
	<keyword>MRI Gadolinium</keyword>
	<keyword>Cervical Dystonia</keyword>
	<keyword>intramuscular injection</keyword>
	<keyword>cervical dystonia ,</keyword>
</DOC>